These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 12421676

  • 1. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.
    Kallen KJ.
    Biochim Biophys Acta; 2002 Nov 11; 1592(3):323-43. PubMed ID: 12421676
    [Abstract] [Full Text] [Related]

  • 2. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S.
    Eur J Biochem; 2001 Jan 11; 268(1):160-7. PubMed ID: 11121117
    [Abstract] [Full Text] [Related]

  • 3. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

  • 4. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    Int Immunol; 1996 Apr 01; 8(4):595-602. PubMed ID: 8722639
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP, Mani JC, Liautard J, Klein B, Brochier J.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):43-8. PubMed ID: 10210772
    [Abstract] [Full Text] [Related]

  • 6. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
    Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT.
    J Biol Chem; 2002 May 10; 277(19):16879-87. PubMed ID: 11884403
    [Abstract] [Full Text] [Related]

  • 7. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
    Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN.
    J Immunol; 1998 Nov 01; 161(9):4992-9. PubMed ID: 9794436
    [Abstract] [Full Text] [Related]

  • 8. The IL-6/sIL-6R complex as a novel target for therapeutic approaches.
    Rose-John S, Waetzig GH, Scheller J, Grötzinger J, Seegert D.
    Expert Opin Ther Targets; 2007 May 01; 11(5):613-24. PubMed ID: 17465721
    [Abstract] [Full Text] [Related]

  • 9. The soluble IL-6 receptors: serum levels and biological function.
    Montero-Julian FA.
    Cell Mol Biol (Noisy-le-grand); 2001 Jun 01; 47(4):583-97. PubMed ID: 11502067
    [Abstract] [Full Text] [Related]

  • 10. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
    Sherwin JR, Smith SK, Wilson A, Sharkey AM.
    J Clin Endocrinol Metab; 2002 Aug 01; 87(8):3953-60. PubMed ID: 12161539
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.
    Kimura T, Sakabe H, Tanimukai S, Abe T, Urata Y, Yasukawa K, Okano A, Taga T, Sugiyama H, Kishimoto T, Sonoda Y.
    Blood; 1997 Dec 15; 90(12):4767-78. PubMed ID: 9389693
    [Abstract] [Full Text] [Related]

  • 12. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.
    Klouche M, Bhakdi S, Hemmes M, Rose-John S.
    J Immunol; 1999 Oct 15; 163(8):4583-9. PubMed ID: 10510402
    [Abstract] [Full Text] [Related]

  • 13. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
    Erices A, Conget P, Rojas C, Minguell JJ.
    Exp Cell Res; 2002 Oct 15; 280(1):24-32. PubMed ID: 12372336
    [Abstract] [Full Text] [Related]

  • 14. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling.
    Sui X, Tsuji K, Ebihara Y, Tanaka R, Muraoka K, Yoshida M, Yamada K, Yasukawa K, Taga T, Kishimoto T, Nakahata T.
    Blood; 1999 Apr 15; 93(8):2525-32. PubMed ID: 10194431
    [Abstract] [Full Text] [Related]

  • 15. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S, Waetzig GH, Chalaris A, Rabe B, Seegert D, Scheller J, Rose-John S, Grötzinger J.
    J Biol Chem; 2008 Oct 03; 283(40):27200-7. PubMed ID: 18650419
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST, Toellner S, Marx K, Faendrich F, Kallen KJ, Schroeder J, Haier J, Kahlke V.
    J Surg Res; 2009 Dec 03; 157(2):235-42. PubMed ID: 19589542
    [Abstract] [Full Text] [Related]

  • 17. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
    Yoshida S, Harada T, Iwabe T, Taniguchi F, Mitsunari M, Yamauchi N, Deura I, Horie S, Terakawa N.
    Hum Reprod; 2004 Aug 03; 19(8):1821-5. PubMed ID: 15166129
    [Abstract] [Full Text] [Related]

  • 18. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
    Igaz P, Horváth A, Horváth B, Szalai C, Pállinger E, Rajnavölgyi E, Tóth S, Rose-John S, Falus A.
    Immunol Lett; 2000 Mar 01; 71(3):143-8. PubMed ID: 10722865
    [Abstract] [Full Text] [Related]

  • 19. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.
    Lee SY, Buhimschi IA, Dulay AT, Ali UA, Zhao G, Abdel-Razeq SS, Bahtiyar MO, Thung SF, Funai EF, Buhimschi CS.
    J Immunol; 2011 Mar 01; 186(5):3226-36. PubMed ID: 21282511
    [Abstract] [Full Text] [Related]

  • 20. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
    Kovacs E, Kuehn JJ.
    Biomed Pharmacother; 2002 May 01; 56(3):152-8. PubMed ID: 12046687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.